SPECTRA supports research teams developing individualized autism assessments, interventions, and everyday technologies to improve health, communication, independence, and quality of life across the lifespan.
TA4 full proposals, previously listed as “dates to be announced,” now open November 23, 2026 and close January 6, 2027 at 3 p.m. ET. Individuals may now lead one submission per TA rather than one overall; TA1 budgeting, data-sharing requirements, and other technical details also changed.
Funder: Advanced Research Projects Agency for Health
Due Dates: October 21, 2026 (TA4 summary) | December 2, 2026 (TA1 & TA2 summaries) | January 6, 2027 (TA4 proposal) | January 19, 2027 (TA3 summary)
Funding Amounts: No individual-project funding limits or range; TA1: 46 months; TA4: 48 months
Summary: Supports autism research, federated AI, tailored interventions, and everyday assessment technologies to improve health, independence, and quality of life.
Key Information: A mandatory Solution Summary must precede a full proposal for every technical area.
SPECTRA is an Advanced Research Projects Agency for Health (ARPA-H) program supporting cross-disciplinary research and technology development for individualized autism assessment, interventions, and support across the lifespan. It emphasizes objective, multifactor measurement and computation to understand how genetic, environmental, family, metabolic, immune, microbiome, and developmental factors interact to shape health, communication, and functional trajectories.
The program connects trajectory analysis, privacy-preserving federated AI, rigorous intervention testing, and accessible technologies that measure function during everyday use. Its goals are better health, quality of life, independence, and autonomy, with continuous assessment integrated into ordinary life. Consultation with autistic people and families grounds the work in lived experience. SPECTRA funds original or additional research, rather than scaling existing programs.